Evaluation of Alexithymia in Chronic Pain Patients With Spinal Cord Stimulation
RecruitingNCT07696286
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to investigate the relationship between alexithymia levels and clinical parameters, including pain intensity and quality of life, in chronic pain patients treated with spinal cord stimulation (SCS). Chronic neuropathic pain can lead to psychological distress and decreased quality of life. While SCS is an effective neuromodulation therapy for managing refractory pain, patient outcomes vary significantly, suggesting that biomedically similar patients experience different levels of relief due to psychosocial factors. Alexithymia, characterized by difficulties in identifying and describing emotions, may significantly influence the individual pain experience and treatment outcomes. In this cross-sectional observational study, patients who underwent SCS implantation for clinical indications will be evaluated. Clinical data regarding pain history will be collected retrospectively from patient files, while psychosocial profiles will be assessed at a single time point using validated psychometric questionnaires. The study aims to contribute to a better understanding of psychosocial variables in neuromodulation outcomes, potentially aiding in improved patient selection and expectation management.
Study details
- Official title
- The Relationship of Alexithymia With Pain and Quality of Life Scales in Chronic Pain Patients Who Underwent Spinal Cord Stimulation: A Cross-Sectional Observational Study
- Conditions
- Interventions
- Other: Psychometric Questionnaires and Retrospective Data Collection
- Sponsor
- Marmara University
- Start date
- 2026-06-01
- Primary completion
- 2026-12-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * \- Being 18 years of age or older * Having undergone permanent spinal cord stimulation (SCS) implantation due to clinical indications * Providing written informed consent for study participation * Being literate * Having the cognitive capacity to complete the psychometric scales * No active, severe psychiatric disorders requiring immediate treatment (e.g., schizophrenia, bipolar affective disorder, severe psychotic disorders) Exclusion Criteria: * Cognitive impairment or communication barriers that compromise the capacity to provide informed consent * Presence of active psychotic disorders or manic episodes * Suspected self-harm or suicide risk during the clinical interview * Presence of specific secondary causes that could explain the pain (e.g., active malignancy, active infection, acute fracture)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07696286